Head-To-Head Survey: Seer (NASDAQ:SEER) and Waters (NYSE:WAT)

Seer (NASDAQ:SEERGet Rating) and Waters (NYSE:WATGet Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.

Valuation & Earnings

This table compares Seer and Waters’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Seer $6.62 million 68.76 -$71.17 million ($1.27) -5.74
Waters $2.79 billion 6.72 $692.84 million $11.43 27.19

Waters has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

86.9% of Seer shares are owned by institutional investors. Comparatively, 90.7% of Waters shares are owned by institutional investors. 28.9% of Seer shares are owned by insiders. Comparatively, 0.8% of Waters shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Seer and Waters, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Seer 0 1 1 0 2.50
Waters 0 5 2 0 2.29

Seer currently has a consensus price target of $21.00, indicating a potential upside of 188.07%. Waters has a consensus price target of $361.00, indicating a potential upside of 16.14%. Given Seer’s stronger consensus rating and higher probable upside, analysts clearly believe Seer is more favorable than Waters.

Risk & Volatility

Seer has a beta of 3.13, indicating that its share price is 213% more volatile than the S&P 500. Comparatively, Waters has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.

Profitability

This table compares Seer and Waters’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Seer -794.43% -15.44% -14.71%
Waters 24.57% 221.08% 23.37%

Summary

Waters beats Seer on 9 of the 14 factors compared between the two stocks.

About Seer (Get Rating)

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

About Waters (Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.